[Adjuvant chemotherapy based on evidence-based medicine for breast cancer patients].

@article{Tokudome2006AdjuvantCB,
  title={[Adjuvant chemotherapy based on evidence-based medicine for breast cancer patients].},
  author={Nahomi Tokudome and Yoshinori Ito},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={2006},
  volume={33 3},
  pages={
          318-23
        }
}
Adjuvant chemotherapy for breast cancer patients has been derived from the results of various clinical studies and metaanalysis. Currently, an anthracycline-containing regimen is a standard chemotherapy for node-negative breast cancer patients with any risk of recurrence. Node-positive breast cancer patients employ AC followed by taxane. The concept of dose-dense therapy or adjuvant trastuzumab for HER 2-positive breast cancer patients will be introduced in the near future. We have to catch the… CONTINUE READING